Cargando…

Low Peak Inspiratory Flow Rates are Common Among COPD Inpatients and are Associated with Increased Healthcare Resource Utilization: A Retrospective Cohort Study

BACKGROUND: Patients with chronic obstructive pulmonary disease (COPD) can have low peak inspiratory flow (PIF), especially after hospitalization for acute exacerbation of COPD (AECOPD). PURPOSE: To characterize patients hospitalized for AECOPD, and to assess the prevalence of low PIF, changes in PI...

Descripción completa

Detalles Bibliográficos
Autores principales:	Clark, Brendan, Wells, Brian J, Saha, Amit K, Franchino-Elder, Jessica, Shaikh, Asif, Donato, Bonnie M K, Ohar, Jill A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9250781/ https://www.ncbi.nlm.nih.gov/pubmed/35791340 http://dx.doi.org/10.2147/COPD.S355772

Ejemplares similares

Prevalence and factors associated with suboptimal peak inspiratory flow rates in COPD
por: Ghosh, Sohini, et al.
Publicado: (2019)

Clinical Implications of Peak Inspiratory Flow in COPD: Post Hoc Analyses of the TRONARTO Study
por: Mahler, Donald A, et al.
Publicado: (2023)

Evaluation of Suboptimal Peak Inspiratory Flow in Patients with Stable COPD
por: Represas-Represas, Cristina, et al.
Publicado: (2020)

Measuring Peak Inspiratory Flow in Patients with Chronic Obstructive Pulmonary Disease
por: Ohar, Jill A, et al.
Publicado: (2022)

Evaluation of Peak Inspiratory Flow Rate in Hospitalized Palliative Care Patients with COPD
por: Borris, Joshua, et al.
Publicado: (2023)

TRONARTO: A Randomized, Placebo-Controlled Study of Tiotropium/Olodaterol Delivered via Soft Mist Inhaler in COPD Patients Stratified by Peak Inspiratory Flow
por: Mahler, Donald A, et al.
Publicado: (2021)

Peak Inspiratory Flow Rate in COPD: An Analysis of Clinical Trial and Real-World Data
por: Anderson, Martin, et al.
Publicado: (2021)

Peak-Inspiratory-Flow-Rate Guided Inhalation Therapy Reduce Severe Exacerbation of COPD
por: Chen, Shih-Yu, et al.
Publicado: (2021)

Prospective Evaluation of Exacerbations Associated with Suboptimal Peak Inspiratory Flow Among Stable Outpatients with COPD
por: Mahler, Donald A, et al.
Publicado: (2022)

Suboptimal Peak Inspiratory Flow and Critical Inhalation Errors are Associated with Higher COPD-Related Healthcare Costs
por: Leving, Marika T, et al.
Publicado: (2022)

Relationship between Peak Inspiratory Flow and Patient and Disease Characteristics in Individuals with COPD—A Systematic Scoping Review
por: Leving, Marika T., et al.
Publicado: (2022)

Patient Inspiratory Maneuver Performance; Peak Lungpower, Acceleration and Volume
por: Haikarainen, Jussi, et al.
Publicado: (2020)

Benefits of short inspiratory muscle training on exercise capacity, dyspnea, and inspiratory fraction in COPD patients
por: Shahin, Barakat, et al.
Publicado: (2008)

Effect of the Inspiratory Method and Timing of Voluntary Cough on Peak Cough Flow
por: Kotajima, Fumiya, et al.
Publicado: (2023)

Risk of hospitalization in a sample of COVID-19 patients with and without chronic obstructive pulmonary disease
por: Myers, Laura C., et al.
Publicado: (2023)

Inspiratory muscle strength and walking capacity in patients with COPD
por: Kofod, Linette Marie, et al.
Publicado: (2019)

Healthcare Resource Utilization, Cost and Clinical Outcomes in Patients Diagnosed with COPD Initiating Tiotropium Bromide/Olodaterol versus Fluticasone Furoate/Umeclidinium/Vilanterol Based on Exacerbation History
por: Sethi, Sanjay, et al.
Publicado: (2023)

Peak Inspiratory Flow Rate: An Emerging Biomarker in Chronic Obstructive Pulmonary Disease
por: Mahler, Donald A.
Publicado: (2019)

Evaluating peak inspiratory pressures and tidal volume in premature neonates on NAVA ventilation
por: Protain, Alison P., et al.
Publicado: (2020)

Peak Nasal Inspiratory Flow Evaluation as an objective method of measuring nasal airflow
por: Teixeira, Rodrigo Ubiratan Franco, et al.
Publicado: (2015)

Dual therapy strategies for COPD: the scientific rationale for LAMA + LABA
por: Cohen, Joshua S, et al.
Publicado: (2016)

Effect of inhaled budesonide/formoterol fumarate dihydrate delivered via two different devices on lung function in patients with COPD and low peak inspiratory flow
por: Huber, Bärbel, et al.
Publicado: (2022)

Clinical relevance of maximal inspiratory pressure: determination in COPD exacerbation
por: Tudorache, Voicu, et al.
Publicado: (2010)

Inspiratory drive is related to dynamic pulmonary hyperinflation in COPD patients
por: Gatta, Diego, et al.
Publicado: (2013)

Effects of inspiratory muscle training on dynamic hyperinflation in patients with COPD
por: Petrovic, Milos, et al.
Publicado: (2012)

A comprehensive care plan that reduces readmissions after acute exacerbations of COPD
por: Ohar, J.A., et al.
Publicado: (2018)

Role of Peak Nasal Inspiratory Flow for Measuring the Effectiveness of Surgery in Children with Adenoidal Hypertrophy
por: Cengiz, Abdurrahman B, et al.
Publicado: (2020)

Effect of Gender on Lung Function and Patient-Reported Outcomes in Patients with COPD Receiving Nebulized Glycopyrrolate
por: Ohar, Jill A, et al.
Publicado: (2020)

32 Peak Nasal Inspiratory Flow Levels in Children With Allergic Rhinitis and Their Health Related Quality of Life (HRQL)
por: Nagaraju, Major K.
Publicado: (2012)

Physiological predictors Of peak inspiRatory flow using Observed lung function resultS (POROS): evaluation at discharge among patients hospitalized for a COPD exacerbation
por: Price, David B, et al.
Publicado: (2018)

Usefulness of inspiratory capacity measurement in COPD patients in the primary care setting
por: Madueño, Antonio, et al.
Publicado: (2009)

Effects of combined tiotropium/olodaterol on inspiratory capacity and exercise endurance in COPD
por: O'Donnell, Denis E., et al.
Publicado: (2017)

The BODE index and inspiratory muscle performance in COPD: Clinical findings and implications
por: Formiga, Magno F, et al.
Publicado: (2018)

Are the “critical” inspiratory constraints actually decisive to limit exercise tolerance in COPD?
por: Marillier, Mathieu, et al.
Publicado: (2020)

Inspiratory crackles—early and late—revisited: identifying COPD by crackle characteristics
por: Melbye, Hasse, et al.
Publicado: (2021)

Efficacy and safety of a novel, nebulized glycopyrrolate for the treatment of COPD: effect of baseline disease severity and age; pooled analysis of GOLDEN 3 and GOLDEN 4
por: Ohar, Jill, et al.
Publicado: (2018)

The Role of ICS/LABA Fixed-Dose Combinations in the Treatment of Asthma and COPD: Bioequivalence of a Generic Fluticasone Propionate-Salmeterol Device
por: Tashkin, Donald P., et al.
Publicado: (2021)

Effect of compliance with GOLD treatment recommendations on COPD health care resource utilization, cost, and exacerbations among patients with COPD on maintenance therapy
por: Palli, Swetha R, et al.
Publicado: (2021)

Paired inspiratory-expiratory chest CT scans to assess for small airways disease in COPD
por: Hersh, Craig P, et al.
Publicado: (2013)

Reply to Mahler: Peak Inspiratory Flow Rate: An Emerging Biomarker in Chronic Obstructive Pulmonary Disease
por: Wu, Ann Chen, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_49eenv2fbc5ri3lvl5h0psp43q